Basilea Pharmaceutica AG (LON:0QNA)
London · Delayed Price · Currency is GBP · Price in CHF 45.84
-0.72 (-1.54%)
At close: Sep 15, 2025
Basilea Pharmaceutica AG Market Cap
Basilea Pharmaceutica AG has a market cap or net worth of 524.33 million as of September 17, 2025. Its market cap has increased by 4.51% in one year.
Market Cap
524.33M
Enterprise Value
494.97M
Revenue
216.79M
Ranking
n/a
PE Ratio
7.86
Stock Price
45.84
Market Cap Chart
Since March 25, 2004, Basilea Pharmaceutica AG's market cap has increased from 231.10M to 524.33M, an increase of 126.88%. That is a compound annual growth rate of 3.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 524.33M | 18.74% |
| Dec 30, 2024 | 441.59M | 12.00% |
| Dec 29, 2023 | 394.28M | -19.52% |
| Dec 30, 2022 | 489.93M | 24.72% |
| Dec 30, 2021 | 392.83M | -17.81% |
| Dec 30, 2020 | 477.95M | 20.82% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 182.89B |
| GSK plc | 60.53B |
| Haleon | 32.39B |
| Smith & Nephew | 12.20B |
| ConvaTec Group | 4.78B |
| Hikma Pharmaceuticals | 3.61B |
| HUTCHMED (China) | 2.23B |
| Genus | 1.72B |